Predicting malignancy in small testicular lesions
- PMID: 35591957
- PMCID: PMC9074063
- DOI: 10.5173/ceju.2022.0206
Predicting malignancy in small testicular lesions
Abstract
Introduction: Small testicular lesions ≤20 mm (STL) detected by ultrasound (US), usually non-palpable, have been reported to be benign in up to 80% of cases. Thus, partial orchiectomy with or without frozen section examination and surveillance has been advocated for these kinds of lesions. We seek to report the proportion of benign lesions in testicular tumors ≤20 mm detected by US in our population and explore the predicting factors of malignancy.
Material and methods: A retrospective descriptive study of orchiectomies performed for testicular tumors in patients older than 15 years between 2005 and 2019 was performed, including all patients with lesions ≤20 mm on US imaging.
Results: A total of 70 patients with STL were included (mean age 34.6 ±10.8 years). Overall, 69% of the lesions were malignant while the smallest lesions (≤10 mm) showed 61% of cancer. Moreover, in the subgroup of non-palpable lesions ≤10 mm, 50% were malignant. Multifocal tumors were found in 18 subjects with a malignancy rate of 88%. There was a significant association between maximum size on US, multifocality and malignancy. Neither tumor markers nor palpability foretold a malignant lesion. A predictive model including size and multifocality was created showing a positive predictive value of 83.3%.
Conclusions: US maximum size and multifocality were predictors of malignancy in STL. However, even the smallest lesions showed a 50% chance of being malignant, thus surgery with or without intraoperative biopsy is warranted in most cases.
Keywords: biopsy; orchiectomy; small testicular mass; testicular neoplasms; testis; ultrasonography.
Copyright by Polish Urological Association.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Laguna MP, Albers P, Algaba F, et al. Testicular Cancer. EAU Guidelines; Edn. presented at the EAU Annual Congress Milan 2021; ISBN 978-94-92671-13-4.
-
- Petersen PM, Skakkebaek NE, Rørth M, Giwercman A. Semen Quality and Reproductive Hormones Before and After Orchiectomy in Men with Testicular Cancer. J Urol. 1999;161:822–826. - PubMed
-
- Nord C, Bjøro T, Ellingsen D, et al. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol. 2003;44:322–328. - PubMed
-
- Carmignani L, Gadda F, Gazzano G, et al. High incidence of benign testicular neoplasms diagnosed by US. J Urol. 2003;170:1783–1786. - PubMed
LinkOut - more resources
Full Text Sources